SCT630

BIOLOGICAL2 trials

Sponsors

Sinocelltech Ltd.

Conditions

HealthyPsoriasis

Phase 1

Pharmacokinetics and Safety in Healthy Volunteers

CompletedNCT03917628

Sinocelltech Ltd.Healthy

Start: 2019-05-29End: 2019-11-04Updated: 2021-01-29

Phase 3

The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

Sinocelltech Ltd.Psoriasis

Start: 2019-09-05End: 2022-12-31Target: 330Updated: 2021-01-29